September 2020

Letter from the Editor

September 1, 2020

What’s Next … Over the past several months, I, like everyone else, have wondered what’s next? What’s next if there’s not a vaccine approved soon? And, even if a vaccine is approved, how does that play out? What happens if there’s a next wave of COVID-19 that coincides with flu season? The what ifs are […]

Upfront

September 1, 2020

Bristol Myers Squibb Commits $300 Million to Health Equity and Diversity and Inclusion Efforts Bristol Myers Squibb and the BMS Foundation are investing $300 million over the next five years to accelerate and sustain its diversity, equity, and inclusion efforts. Specifically, the company will focus on five key areas to effect change across all aspects […]

HealthTech

September 1, 2020

Amwell Telehealth Use Swells During Pandemic Trend Watch: Technology Rises to the Challenges of COIVD-19 Amwell, a national telehealth company, which has been gaining app usage since the onslaught of COVID-19, has hired a new Chief Technology Officer Serkan Kutan. Mr. Kutan who comes from executive positions at Haven and Zocdoc has joined the company […]

Artificial Intelligence

September 1, 2020

SOPHiA Genetics’ First Multimodal Approach to Predict COVID-19 Disease Evolution Trend Watch: AI Technology Helps in the Fight Against COVID-19 Health-tech company SOPHiA Genetics, specializing in data-driven medicine, has launched a first-of-its-kind multimodal solution to predict COVID-19 disease evolution, opening new dimensions of insight into the fight against the worldwide pandemic. This advancement goes beyond […]

Innovator’s Corner

September 1, 2020

Turning on the Switch Fulcrum’s proprietary product engine identifies drug targets that can modulate gene expression to treat the known root cause of gene mis-expression. Bringing more than 30 years of R&D experience to his role as president and CEO of Fulcrum Therapeutics, Robert Gould, Ph.D., joined the company at its launch in 2016. In […]

Last Word

September 1, 2020

Changing the Patient–Scientist Dialogue Paul Kidwell, Senior Public Relations/Patient Advocacy Consultant & Podcaster, for the life-sciences industry provides an insider’s view into the need for increased communication between patients and scientists. PV: What has been your experience in terms of the typical interaction between patients and biopharma scientists? Kidwell: When scientists communicate regularly, clearly, and […]

What’s Next Post-COVID-19: The Next Normal

September 1, 2020

From R&D to commercial operations, stakeholders across the healthcare ecosystem are adjusting to the next phase of the pandemic: business in a new reality. With some experts predicting that the “normalization” of business operations could be several months to a year away as the world awaits a vaccine or vaccines, organizations across the life-sciences industry […]

SHOWCASE: Big Data: Big is Better: The Importance of Data in Industry Advances

September 1, 2020

Big data is big business, and for the life-sciences and healthcare industries it’s playing an important role in informing everything from R&D to commercialization. With the growth of digital healthcare, it is estimated that the amount of data the industry is collecting is increasing by around 50% per year. The healthcare and life-sciences industries have […]

Why Are We Settling for Mediocre Patient Services Programs?

September 1, 2020

Meet Dorothy: mother of twin 12-year-old girls who inherited her natural talent and love for tennis. Every weekend she coaches their junior team and analyzes each match on their way to get pizza. Dorothy thrives on the tennis court next to her girls; she feels energized and empowered. Monday mornings, on the other hand, don’t […]

The Fabric of Data Cognizance

September 1, 2020

Effective data businesses have always been built on a foundation of individual honesty. Leaders faced with big decisions have been quick to listen to what their patients and employees tell them, but have also been slower to make judgments based on their gut instincts. The reason? EHR data just weren’t always available. Over the course […]

Will Big Data Fundamentally Change Our Approach to the Next Pandemic?

September 1, 2020

Big Data…Hero at Large? The current COVID-19 pandemic has forced a rethink of drug discovery and healthcare management. Over the first half of 2020, we have seen an unprecedented speed of candidate drug evaluation for the treatment of COVID-19 and the development of vaccines directed against SARS-CoV-2. According to the latest data from the WHO, […]

Turning Data into Storytelling

September 1, 2020

Beyond communications skills, creating a good data story requires research. Nobody wants to listen to a boring story. And for some, data can be boring, or at best, confusing. Telling an enthralling story takes a certain skill, and when the topic is a mound of eye-glazing data and analysis, it becomes even more difficult to […]

SHOWCASE: Digital Marketing: AI, VR, AR: A New Age of Digital Tools Changes the Game for Marketers

September 1, 2020

Whether it’s social media forums, internal digital platforms, AI-powered apps and chat bots, or augmented and virtual reality, the digital tools open to the pharma industry today are changing the face of marketing. More and more pharma companies are using digital tools to reach their audiences. According to one survey, more than 50% of companies […]

Leveraging Data and Machine Learning to Drive Brand Performance

September 1, 2020

There is no question that 2020 has been a year like none other, especially for those in the healthcare industry. For brand managers, that meant sales teams were grounded; budgets got frozen, or even cut in many cases; healthcare practitioners moved their offices virtual; and telehealth services jumped light-years ahead in terms of usage and […]

Driving Digital Strategy Forward: Customer Engagement in COVID-19 and Beyond

September 1, 2020

The life-sciences industry is starting to find a new baseline, adapting to the abrupt remote digital pivot many organizations needed to make. While we acknowledge in recent years the industry has been on a path toward digital transformation, there’s no denying that the complications arising from the COVID-19 pandemic have accelerated that process for many […]

We’re All Digital Natives

September 1, 2020

We’ve all heard the term “flatten the curve” to describe the efforts being made to curb infection rates of COVID-19, but today’s tumultuous climate is disrupting another curve — the adoption curve of digital health. In 2019, a survey revealed that two-thirds of patients were open to the idea of telehealth, but only 8% had […]

Convention Tactics in a POST-COVID-19 Environment

September 1, 2020

The beginning of 2020 presented some extremely unique circumstances for everyone. It didn’t take long to realize life was going to change on a personal and professional level. As the quarantine started, and the medical congresses for the rest of 2020 were being canceled, agencies knew their marketing strategies had to adapt fast. Clients were […]

Accessible Healthcare: The Key Role of Health Literacy

September 1, 2020

Health literacy can have a significant bearing on outcomes, so helping patients understand their health and treatments is critical. Health information is by its very nature complex. Explaining a disease or how to take a drug or a drug’s potential side effects to a patient can be difficult and can prevent patients from making informed […]

Commanders & Chiefs: Chief Medical Officers

September 1, 2020

Chief Medical Officers have a big remit when it comes to overseeing their organization’s clinical trial strategies as well as keeping the patient voice top of mind. Dr. David Andrews Tracking Neo-Antigens The biggest trend in the immuno-oncology space is the pursuit of a successful solid tumor immunotherapy, which would be a major breakthrough for […]

Speak Out: From Crawl to Run: Maturing Digital Engagement

September 1, 2020

In the last 5 years, the pharmaceutical industry has taken clear steps towards omnichannel engagement. In the last 5 months, the walking — and sometimes crawling — has turned into a race. And not everyone is ready to run. The core drivers of success in pharmaceutical sales have not changed: • Removing barriers to access […]

FEEDBACK